Jay Patel, MD
Hematology · Salt Lake City, UTNPI 1538329867
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $44,565 of the $49,249 with a category attached, or 90.5%. 6 manufacturers reported payments, led by Incyte Corporation at 37.0% of the total. Reporting peaked in 2021 at $31,080 and has fallen 78.7% since, to $6,615 in 2022.
Across 26 payments — averaging $1894.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$18K
- Astellas Pharma Global Development$14K
- Bristol Myers Squibb$9K
- Jazz Pharmaceuticals Inc.$5K
- Blueprint Medicines Corporation$3K
- Abbott$20
Across 10 payments — averaging $866.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$5K
- Bristol Myers Squibb$4K
What the payments were for
- Consulting fees$44,56590%
- Speaking & faculty fees$2,8966%
- Travel & lodging$1,4043%
- Food & beverage$3841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 5 | $18,204 |
| Astellas Pharma Global Development | 4 | $14,250 |
| Bristol Myers Squibb | 8 | $9,044 |
| Jazz Pharmaceuticals Inc. | 7 | $4,959 |
| Blueprint Medicines Corporation | 1 | $2,772 |
| Abbott | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few hematology providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Salt Lake City
- George RodgersSalt Lake City$133K
- Deborah StephensSalt Lake City$98K
- Srinivas TantravahiSalt Lake City$81K
- Daniel ErmannSalt Lake City$74K
- Charles ParkerSalt Lake City$54K
- Josef PrchalSalt Lake City$48K
- Ami PatelSalt Lake City$5K
- Kristi SmockSalt Lake City$4K
- Margaret BaronSalt Lake City$524
- Archana AgarwalSalt Lake City$345
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.